Emergent BioSolutions

Emergent BioSolutions is a biopharmaceutical company headquartered in Rockville, Md. It develops, manufactures and commercializes a range of immunobiotics, including vaccines and therapeutics. Its BioThrax vaccine, approved by the Food and Drug Administration, is used for the prevention of anthrax infection. The company s commercial business focuses on immunobiotics that are used against infectious diseases and other medical conditions. Its commercial portfolio includes vaccines for hepatitis, meningitis and typhoid disorders. Emergent BioSolutions operates various offices in Singapore, Germany and the United Kingdom. It also maintains a network of third-party marketing representatives in the Middle East, Turkey, India, Australia and several Scandinavian countries in Europe.

Immunoclin Corporation is a biotechnology company based in Washington, DC, specializing in the research and development of innovative immunotherapy treatments. With a focus on harnessing the power of the immune system to combat diseases, Immunoclin Corporation is dedicated to advancing medical science and improving patient outcomes through cutting-edge therapies. Generated from their business information

Emergent BioSolutions is a biopharmaceutical company based in Rockville, MD, specializing in the development and manufacturing of vaccines and therapeutics for infectious diseases and public health threats. With a focus on biodefense and emerging infectious diseases, Emergent BioSolutions works to address global health challenges through innovative research, development, and production of medical countermeasures. Generated from their business information